Prior work implicated EZH2 in myeloma cell proliferation and transformation [66], and our data suggest that t(4;14)+ cells may be particularly sensitive to inhibition of EZH2 (Figure 4F; Supplemental Figure S6A). Here, EZH2 is linked to plasma cell myeloma.